Influenza pandemic preparedness plan for the United States

Journal of Infectious Diseases

Volumn 176, Issue SUPPL. 1, 1997, Pages

  Patriarca, Peter A ^a   Cox, Nancy J ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMOPROPHYLAXIS; CHEMOTHERAPY; EMERGENCY MEDICINE; EPIDEMIC; HUMAN; INFECTION CONTROL; INFLUENZA; INFORMATION SYSTEM; MEDICAL RESEARCH; PRIORITY JOURNAL; UNITED STATES; VACCINATION; VACCINE PRODUCTION;

EID: 0030746050     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514174     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996;45(RR-5): 1-24.
2. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988;108:616-25.
3. Glezen WP, Couch RB. Influenza viruses. In: Evans AS, ed. Viral infections of humans. Epidemiology control. New York: Plenum Press, 1989: 419-49.
4. Noble GR. Epidemiological and clinical aspects of influenza. In: Beere AS, ed. Basic and applied influenza research. Boca Raton, FL: CRC Press, 1982:11-50.
5. Webster RG, Kawaoka Y. Influenza - an emerging and re-emerging disease. Semin Virol 1994;5:103-11.
6. Guan Y, Shortridge KF, Krauss S, Li PH, Kawaoka Y, Webster RG. Emergence of avian H1N1 influenza viruses in pigs in China. J Virol 1996;70:8041-6.
7. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18:64-76.
8. Webster RG, Bean WJ, German TO, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79.
9. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 1997;275:1793-6.
10. Crosby AW. America's forgotten pandemic: the influenza of 1918. Cambridge, UK: Cambridge University Press, 1989.
11. Tamblyn SE, Hinman AR. Pandemic planning: conclusions and recommendations. In: Hannoun C, Kendal AP, Klenk HD, Ruben FL, eds. Options for the control of influenza II. Amsterdam: Excerpta Medica, 1993:457-60.
12. Rowe PM. Pandemic influenza (un)preparedness described. Lancet 1995;346:1699.
13. Pennisi E. Experts wary of ever-changing influenza A virus. ASM News 1996;62:356-60.
14. Hilleman MR. Cooperation between government and industry in combating a perceived emerging pandemic. The 1976 swine influenza vaccination program [commentary]. JAMA 1996;275:241-3.
15. Centers for Disease Control and Prevention. Addressing emerging infectious diseases threats. A prevention strategy for the United States. Atlanta: CDC, US Department of Health and Human Services, 1994.
16. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press, 1992.
17. Fedson DS, for National Vaccine Advisory Committee. Adult immunization: summary of the National Vaccine Advisory Committee report. JAMA 1994;272:1133-7.
18. US Department of Health and Human Services. Health and medical services support plan for the Federal response to acts of chemical/biological terrorism. Washington, DC: Office of Emergency Preparedness, 14 May 1996.
19. Cox NJ, Brammer TL, Regnery HL. Influenza: global surveillance for epidemic and pandemic variants. Eur J Epidemiol 1994;10:1-4.
20. Shortridge KF, Stuart-Harris CH. An influenza epicentre? Lancet 1982:2: 812-3.
21. Centers for Disease Control and Prevention. Pneumococcal and influenza vaccination levels among adults aged ≥65 years - United States, 1993. MMWR 1996;45:853-9.
22. Williams MS, Wood JM. A brief history of influenza virus vaccines. In: Hannoun C, Kendal AP, Klenk HD, Ruben FL. eds. Options for the control of influenza II. Amsterdam: Excerpta Medica, 1993:169-70.
23. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
24. Mullooly JP, Bennett MD, Hornbrook MC, et al. Cost-effectiveness of influenza programs for the elderly in a health maintenance organization. Ann Intern Med 1994;121:947-52.
25. Govaert ThME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994;272:1661-5.
26. Gross PA, Hermogenes A, Sachs H, Levandowski RA. The efficacy of influenza vaccine in the elderly: a meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
27. Federal Emergency Management Agency. Federal response plan (for Public Law 93-288, as amended). Washington, DC: FEMA, 1992.